
- Pharmaceutical Executive-03-01-2001
- Volume 0
- Issue 0
Shortage: Vaccine Worries
United States-At this time last year, the United States} supply of tetanus vaccine was easily met by the two companies licensed to produce it there, Aventis Pasteur and Wyeth-Ayerst. But in June 2000, the latter ran into regulatory problems, and FDA seized thousands of substandard doses of acellular pertussis vaccine from the company}s Marietta, Pennsylvania, plant.
Articles in this issue
over 24 years ago
Research: New Horizonsover 24 years ago
Earnings: Tough Times Aheadover 24 years ago
Outbreak: Anthrax Alarmover 24 years ago
Patents: China on the Genome Mapover 24 years ago
Privacy, Pediatrics, and Policyover 24 years ago
Lilly's International Familyover 24 years ago
Update: Punishment and Reprieveover 24 years ago
Gateway to Japanover 24 years ago
SurroundedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





